Publicaciones en colaboración con investigadoras/es de Brigham and Women's Hospital (44)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Hypoxic burden to guide CPAP treatment allocation in patients with obstructive sleep apnoea: a post hoc study of the ISAACC trial

    The European respiratory journal, Vol. 62, Núm. 6

  3. Plasma lipidome and risk of atrial fibrillation: results from the PREDIMED trial

    Journal of Physiology and Biochemistry, Vol. 79, Núm. 2, pp. 355-364

2022

  1. Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects

    Drug Discovery Today, Vol. 27, Núm. 2, pp. 436-455

  2. Arginine catabolism metabolites and atrial fibrillation or heart failure risk: 2 case-control studies within the Prevención con Dieta Mediterránea (PREDIMED) trial

    The American journal of clinical nutrition, Vol. 116, Núm. 3, pp. 653-662

  3. Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers

    Parkinsonism and Related Disorders, Vol. 96, pp. 29-35

  4. Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry

    ESC Heart Failure, Vol. 9, Núm. 4, pp. 2189-2198

  5. Plasma acylcarnitines and risk of incident heart failure and atrial fibrillation: the Prevención con dieta mediterránea study

    Revista Espanola de Cardiologia, Vol. 75, Núm. 8, pp. 649-658

2021

  1. Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study

    Clinical chemistry, Vol. 67, Núm. 1, pp. 288-297

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Metabolomics of the tryptophan-kynurenine degradation pathway and risk of atrial fibrillation and heart failure: potential modification effect of Mediterranean diet

    The American journal of clinical nutrition, Vol. 114, Núm. 5, pp. 1646-1654

2019

  1. Changes in arginine are inversely associated with type 2 diabetes: A case-cohort study in the PREDIMED trial

    Diabetes, Obesity and Metabolism, Vol. 21, Núm. 2, pp. 397-401

  2. Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: Results from two case-cohort studies

    Cardiovascular Diabetology, Vol. 18, Núm. 1

  3. Metabolites related to purine catabolism and risk of type 2 diabetes incidence; modifying effects of the TCF7L2-rs7903146 polymorphism

    Scientific Reports, Vol. 9, Núm. 1

  4. Plasma Metabolites Associated with Frequent Red Wine Consumption: A Metabolomics Approach within the PREDIMED Study

    Molecular Nutrition and Food Research, Vol. 63, Núm. 17

2018

  1. Plasma branched chain/aromatic amino acids, enriched Mediterranean diet and risk of type 2 diabetes: case-cohort study within the PREDIMED Trial

    Diabetologia, Vol. 61, Núm. 7, pp. 1560-1571

  2. Plasma lipidome patterns associated with cardiovascular risk in the PREDIMED trial: A case-cohort study

    International Journal of Cardiology, Vol. 253, pp. 126-132

  3. Plasma trimethylamine-N-oxide and related metabolites are associated with type 2 diabetes risk in the Prevención con Dieta Mediterránea (PREDIMED) trial

    American Journal of Clinical Nutrition, Vol. 108, Núm. 1, pp. 163-173

2017

  1. Plasma arginine/asymmetric dimethylarginine ratio and incidence of cardiovascular events: A case-cohort study

    Journal of Clinical Endocrinology and Metabolism, Vol. 102, Núm. 6, pp. 1879-1888

  2. Plasma ceramides, mediterranean diet, and incident cardiovascular disease in the PREDIMED trial (prevención con dieta mediterránea)

    Circulation, Vol. 135, Núm. 21, pp. 2028-2040